Drugs & medicalClass II

Apotex Corp. recalls Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC…

Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.

Read the official notice →
Date
2022-07-27
Country
United States
Brand
Apotex
Product
Aripiprazole Tablets, USP 20 mg, packaged in a) 1,000-count bottle (NDC 60505-2676-8, UPC 3 60505 26768 2), b) 30-count bottle (NDC…
Classification
Class II
Units
USA Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Apotex recalls

  1. 2024-02-28
  2. US
    Drugs & medicalClass II

    Apotex Corp. recalls Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario…

    CGMP Deviations: potential presence of Burkholderia cepacia complex

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →
  3. 2023-12-06
  4. US
    Drugs & medicalClass II

    Apotex Corp. recalls Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-count bottle, NDC#:60505-0084-2,…

    Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine

    FDA · DrugApotex Corp.NationwideOfficial notice →
  5. 2023-05-17
  6. US
    Drugs & medicalClass II

    Apotex Corp. recalls Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP Calcitonin Salmon Units/spray, 3.7 mL…

    Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.

    FDA · DrugApotex Corp.Nationwide throughout the United StatesOfficial notice →
  7. 2023-03-15
  8. US
    Drugs & medicalClass II

    Apotex Corp. recalls Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper bottle, NDC 60505-0564-1, UPC 3 60505 05641 5; b) 10…

    Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →
  9. 2023-01-04
  10. US
    Drugs & medicalClass III

    Apotex Corp. recalls Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp.…

    Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

    FDA · DrugApotex Corp.USA NationwideOfficial notice →
  11. 2022-05-25
  12. US
    Drugs & medicalClass III

    Apotex Corp. recalls Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for:…

    Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

    FDA · DrugApotex Corp.Nationwide in the USAOfficial notice →
All 14 Apotex recalls →

Other drugs & medical recalls in the United States

  1. 2022-07-27
  2. US
    Drugs & medicalClass II

    Loud Muscle Science recalls Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

    Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

    FDA · DrugLoud Muscle ScienceThe product was distributed nationwide in the USA and Canada.Official notice →
  3. US
    Drugs & medicalClass I

    Loud Muscle Science recalls Launch Sequence Aphrodisia Capsules, 4-count tins, ASIN B07QB3S2LV, UPC Code 661020846957.

    Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.

    FDA · DrugLoud Muscle ScienceThe product was distributed nationwide in the USA and Canada.Official notice →
  4. US
    Drugs & medicalClass I

    Amazon.com, Inc. recalls Artri Ajo King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO ,…

    Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.

    FDA · DrugAmazon.com, Inc.Nationwide within the U.S.A.Official notice →
  5. US
    Drugs & medicalClass II

    CIPLA recalls Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S Indoco Remedies Limited., L-32, 33, 34,…

    Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

    FDA · DrugCIPLANationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark…

    Failed Tablet/Capsule Specification : Capsule breakage

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA NationwideOfficial notice →
  7. US
See all drugs & medical recalls →